Literature DB >> 23112170

Modification of ghrelin receptor signaling by somatostatin receptor-5 regulates insulin release.

Seongjoon Park1, Hong Jiang, Hongjie Zhang, Roy G Smith.   

Abstract

Both ghrelin and somatostatin (SST) inhibit glucose-stimulated insulin secretion (GSIS) from pancreatic β-cells, but how these independent actions are regulated has been unclear. The mechanism must accommodate noncanonical ghrelin receptor (GHS-R1a)-G-protein coupling to Gα(i/o) instead of Gα(q11) and dependence on energy balance. Here we present evidence for an equilibrium model of receptor heteromerization that fulfills these criteria. We show that GHS-R1a coupling to Gα(i/o) rather than Gα(q11) requires interactions between GHS-R1a and SST receptor subtype 5 (SST5) and that in the absence of SST5 ghrelin enhances GSIS. At concentrations of GHS-R1a and SST5 expressed in islets, time-resolved FRET and bioluminescence resonance energy transfer assays illustrate constitutive formation of GHS-R1a:SST5 heteromers in which ghrelin, but not SST, suppresses GSIS and cAMP accumulation. GHS-R1a-G-protein coupling and the formation of GHS-R1a:SST5 heteromers is dependent on the ratio of ghrelin to SST. A high ratio enhances heteromer formation and Gα(i/o) coupling, whereas a low ratio destabilizes heteromer conformation, restoring GHS-R1a-Gα(q11) coupling. The [ghrelin]/[SST] ratio is dependent on energy balance: Ghrelin levels peak during acute fasting, whereas postprandially ghrelin is at a nadir, and islet SST concentrations increase. Hence, under conditions of low energy balance our model predicts that endogenous ghrelin rather than SST establishes inhibitory tone on the β-cell. Collectively, our data are consistent with physiologically relevant GHS-R1a:SST5 heteromerization that explains differential regulation of islet function by ghrelin and SST. These findings reinforce the concept that signaling by the G-protein receptor is dynamic and dependent on protomer interactions and physiological context.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23112170      PMCID: PMC3503195          DOI: 10.1073/pnas.1209590109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers.

Authors:  M Rocheville; D C Lange; U Kumar; R Sasi; R C Patel; Y C Patel
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

2.  Ghrelin and growth hormone: story in reverse.

Authors:  Ralf M Nass; Bruce D Gaylinn; Alan D Rogol; Michael O Thorner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-30       Impact factor: 11.205

3.  Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism.

Authors:  Andras Kern; Rosie Albarran-Zeckler; Heidi E Walsh; Roy G Smith
Journal:  Neuron       Date:  2012-01-26       Impact factor: 17.173

4.  The preproghrelin gene is required for the normal integration of thermoregulation and sleep in mice.

Authors:  Eva Szentirmai; Levente Kapás; Yuxiang Sun; Roy G Smith; James M Krueger
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-04       Impact factor: 11.205

5.  Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice.

Authors:  Tong-Jin Zhao; Guosheng Liang; Robert Lin Li; Xuefen Xie; Mark W Sleeman; Andrew J Murphy; David M Valenzuela; George D Yancopoulos; Joseph L Goldstein; Michael S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

6.  Ghrelin directly stimulates glucagon secretion from pancreatic alpha-cells.

Authors:  Jen-Chieh Chuang; Ichiro Sakata; Daisuke Kohno; Mario Perello; Sherri Osborne-Lawrence; Joyce J Repa; Jeffrey M Zigman
Journal:  Mol Endocrinol       Date:  2011-06-30

7.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

8.  Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion.

Authors:  H E Hohmeier; H Mulder; G Chen; R Henkel-Rieger; M Prentki; C B Newgard
Journal:  Diabetes       Date:  2000-03       Impact factor: 9.461

9.  Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization.

Authors:  Damien Maurel; Laëtitia Comps-Agrar; Carsten Brock; Marie-Laure Rives; Emmanuel Bourrier; Mohammed Akli Ayoub; Hervé Bazin; Norbert Tinel; Thierry Durroux; Laurent Prézeau; Eric Trinquet; Jean-Philippe Pin
Journal:  Nat Methods       Date:  2008-05-18       Impact factor: 28.547

10.  Somatostatin secreted by islet delta-cells fulfills multiple roles as a paracrine regulator of islet function.

Authors:  Astrid C Hauge-Evans; Aileen J King; Danielle Carmignac; Carolyn C Richardson; Iain C A F Robinson; Malcolm J Low; Michael R Christie; Shanta J Persaud; Peter M Jones
Journal:  Diabetes       Date:  2008-11-04       Impact factor: 9.461

View more
  38 in total

1.  Orexin A/Hypocretin Modulates Leptin Receptor-Mediated Signaling by Allosteric Modulations Mediated by the Ghrelin GHS-R1A Receptor in Hypothalamic Neurons.

Authors:  Mireia Medrano; David Aguinaga; Irene Reyes-Resina; Enric I Canela; Josefa Mallol; Gemma Navarro; Rafael Franco
Journal:  Mol Neurobiol       Date:  2017-07-17       Impact factor: 5.590

Review 2.  Fine-tuning somatostatin receptor signalling by agonist-selective phosphorylation and dephosphorylation: IUPHAR Review 5.

Authors:  Stefan Schulz; Andreas Lehmann; Andrea Kliewer; Falko Nagel
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 3.  International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.

Authors:  Thomas Günther; Giovanni Tulipano; Pascal Dournaud; Corinne Bousquet; Zsolt Csaba; Hans-Jürgen Kreienkamp; Amelie Lupp; Márta Korbonits; Justo P Castaño; Hans-Jürgen Wester; Michael Culler; Shlomo Melmed; Stefan Schulz
Journal:  Pharmacol Rev       Date:  2018-10       Impact factor: 25.468

4.  Incretin dysfunction and hyperglycemia in cystic fibrosis: Role of acyl-ghrelin.

Authors:  Xingshen Sun; Yaling Yi; Bo Liang; Yu Yang; Nan He; Katie Larson Ode; Aliye Uc; Kai Wang; Katherine N Gibson-Corley; John F Engelhardt; Andrew W Norris
Journal:  J Cyst Fibros       Date:  2019-02-07       Impact factor: 5.482

5.  Long-term treatment with the ghrelin receptor antagonist [d-Lys3]-GHRP-6 does not improve glucose homeostasis in nonobese diabetic MKR mice.

Authors:  Rasha Mosa; Lili Huang; Hongzhuo Li; Michael Grist; Derek LeRoith; Chen Chen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-09-13       Impact factor: 3.619

Review 6.  Modulation of the adaptive response to stress by brain activation of selective somatostatin receptor subtypes.

Authors:  Andreas Stengel; Jean Rivier; Yvette Taché
Journal:  Peptides       Date:  2012-12-31       Impact factor: 3.750

Review 7.  Ghrelin: much more than a hunger hormone.

Authors:  Geetali Pradhan; Susan L Samson; Yuxiang Sun
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2013-11       Impact factor: 4.294

Review 8.  Modulation of pancreatic exocrine and endocrine secretion.

Authors:  Rashmi Chandra; Rodger A Liddle
Journal:  Curr Opin Gastroenterol       Date:  2013-09       Impact factor: 3.287

9.  The Retinitis Pigmentosa-Linked Mutations in Transmembrane Helix 5 of Rhodopsin Disrupt Cellular Trafficking Regardless of Oligomerization State.

Authors:  D Paul Mallory; Elizabeth Gutierrez; Margaret Pinkevitch; Christie Klinginsmith; William D Comar; Francis J Roushar; Jonathan P Schlebach; Adam W Smith; Beata Jastrzebska
Journal:  Biochemistry       Date:  2018-08-21       Impact factor: 3.162

10.  Endogenous somatostatin is critical in regulating the acute effects of L-arginine on growth hormone and insulin release in mice.

Authors:  Jose Córdoba-Chacón; Manuel D Gahete; Ana I Pozo-Salas; Justo P Castaño; Rhonda D Kineman; Raul M Luque
Journal:  Endocrinology       Date:  2013-05-21       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.